- Home
- MTCH vs ROIV Comparison
MTCH vs ROIV Comparison
Compare MTCH & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTCH
- ROIV
- Stock Information
- Founded
- MTCH 1986
- ROIV 2014
- Country
- MTCH United States
- ROIV United Kingdom
- Employees
- MTCH N/A
- ROIV N/A
- Industry
- MTCH Computer Software: Programming Data Processing
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- MTCH Technology
- ROIV Health Care
- Exchange
- MTCH Nasdaq
- ROIV Nasdaq
- Market Cap
- MTCH 7.2B
- ROIV 8.4B
- IPO Year
- MTCH 2015
- ROIV N/A
- Fundamental
- Price
- MTCH $29.34
- ROIV $10.91
- Analyst Decision
- MTCH Buy
- ROIV Buy
- Analyst Count
- MTCH 19
- ROIV 4
- Target Price
- MTCH $35.89
- ROIV $17.50
- AVG Volume (30 Days)
- MTCH 5.4M
- ROIV 5.5M
- Earning Date
- MTCH 05-08-2025
- ROIV 05-29-2025
- Dividend Yield
- MTCH 1.29%
- ROIV N/A
- EPS Growth
- MTCH N/A
- ROIV N/A
- EPS
- MTCH 2.03
- ROIV N/A
- Revenue
- MTCH $3,450,904,000.00
- ROIV $122,585,000.00
- Revenue This Year
- MTCH $1.20
- ROIV N/A
- Revenue Next Year
- MTCH $4.15
- ROIV N/A
- P/E Ratio
- MTCH $14.48
- ROIV N/A
- Revenue Growth
- MTCH 0.40
- ROIV 140.04
- 52 Week Low
- MTCH $26.39
- ROIV $8.73
- 52 Week High
- MTCH $38.84
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- MTCH 49.09
- ROIV 52.03
- Support Level
- MTCH $28.80
- ROIV $10.58
- Resistance Level
- MTCH $30.45
- ROIV $11.77
- Average True Range (ATR)
- MTCH 1.02
- ROIV 0.33
- MACD
- MTCH 0.08
- ROIV -0.04
- Stochastic Oscillator
- MTCH 59.32
- ROIV 28.57
About MTCH Match Group Inc.
Match Group Inc is a provider of online dating products. The company's portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and more, each built to increase its user's likelihood of connecting with others. The company has four operating segments: Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. The company generates the majority of its revenue from the Tinder segment.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.